Clinical Psychopharmacology and Toxicology
A special issue of Medicines (ISSN 2305-6320).
Deadline for manuscript submissions: 31 March 2025 | Viewed by 117
Special Issue Editor
Special Issue Information
Dear Colleagues,
We encourage you to participate in the upcoming Special Issue and submit their research work in order to contribute to the expansion of rather limited knowledge on the therapeutic use of psychotropic medication, in addition to well-known traditional psychological/psychiatric interventions, for the treatment of mental disorders and promotion of overall patient health and well-being, as well as on overdoses with (il)legal psychoactive substances (including novel compounds).
This Special Issue aims to collect at least 10 valuable papers focused on the topic of Clinical Psychopharmacology and Toxicology. Authors may consider contributing a manuscript that focuses on current issues regarding pharmacological, clinical, and toxicological aspects of psychotropic drugs and psychoactive substances.
In this Special Issue, original research articles and reviews are welcome to be submitted. Research areas may include, but are not limited to, the following: clinical psychopharmacology, clinical toxicology, psychotropic drugs, psychoactive substances, and psychiatry.
We look forward to receiving your contributions.
Dr. Vesna Mijatović-Jovin
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- psychotropic drugs
- psychoactive substances
- novel psychoactive substances
- pharmacology
- toxicology
- overdose
- suicide
- suicide attempt
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
